HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHA patent suit

This article was originally published in The Rose Sheet

Executive Summary

Scott's Liquid Gold subsidiary Neoteric Cosmetics gains non-exclusive right to market skin care products using "certain alpha hydroxy acids for...the reduction of the appearance of skin wrinkles and the reduction in the appearance of skin changes associated with aging" under license agreement between firms announced Dec. 14. Agreement settles patent infringement suit initiated by TriStrata in 1996. TriStrata will receive fixed payment for alleged patent infringements and royalty on future sales of product covered under arrangement. TriStrata, which owns 70 patents protecting its alpha hydroxy technology, recently settled with L'Oreal (1"The Rose Sheet" Nov. 13, In Brief)

You may also be interested in...



AHA patent suit

L'Oreal and TriStrata settle alpha hydroxy acid patent infringement lawsuit filed in Wilmington, Del. federal court, TriStrata parent company NeoStrata announces Nov. 6. TriStrata, which owns 70 patents protecting its alpha hydroxy technology, alleged L'Oreal was using the ingredient without licensing clearance. The firm has similar litigation pending against Clarins, Murad and Neoteric. The company most recently settled with Chanel (1"The Rose Sheet" Aug. 21, In Brief)

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008756

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel